Association O
of O
polygenic O
risk O
for O
major O
psychiatric O
illness O
with O
subcortical O
volumes O
and O
white O
matter O
integrity O
in O
UK O
Biobank O
Major O
depressive O
disorder O
( O
MDD O
) O
, O
schizophrenia O
( O
SCZ O
) O
and O
bipolar O
disorder O
( O
BP O
) O
are O
common O
, O
disabling O
and O
heritable O
psychiatric O
diseases O
with O
a O
complex O
overlapping O
polygenic O
architecture O
. O

Individuals O
with O
these O
disorders O
, O
as O
well O
as O
their O
unaffected O
relatives O
, O
show O
widespread O
structural O
differences O
in O
corticostriatal O
and O
limbic O
networks O
. O

Structural O
variation O
in O
many O
of O
these O
brain O
regions O
is O
also O
heritable O
and O
polygenic O
but O
whether O
their O
genetic O
architecture O
overlaps O
with O
that O
of O
major O
psychiatric O
disorders O
is O
unknown O
. O

We O
sought O
to O
address O
this O
issue O
by O
examining O
the O
impact O
of O
polygenic O
risk O
of O
MDD O
, O
SCZ O
, O
and O
BP O
on O
subcortical O
brain O
volumes O
and O
white O
matter O
( O
WM O
) O
microstructure O
in O
a O
large O
single O
sample O
of O
neuroimaging O
data O
; O
the O
UK O
Biobank O
Imaging O
study O
. O

The O
first O
release O
of O
UK O
Biobank O
imaging O
data O
comprised O
participants O
with O
overlapping O
genetic O
data O
and O
subcortical O
volumes O
( O
N O
= O
978 O
) O
and O
WM O
measures O
( O
N O
= O
816 O
) O
. O

The O
calculation O
of O
polygenic O
risk O
scores O
was O
based O
on O
genome-wide O
association O
study O
results O
generated O
by O
the O
Psychiatric O
Genomics O
Consortium O
. O

Our O
findings O
indicated O
no O
statistically O
significant O
associations O
between O
either O
subcortical O
volumes O
or O
WM O
microstructure O
, O
and O
polygenic O
risk O
for O
MDD O
, O
SCZ O
or O
BP O
. O

These O
findings O
suggest O
that O
subcortical O
brain O
volumes O
and O
WM O
microstructure O
may O
not O
be O
closely O
linked O
to O
the O
genetic O
mechanisms O
of O
major O
psychiatric O
disorders O
. O

Methods O
Study O
population O
The O
first O
release O
of O
UK O
Biobank O
imaging O
data O
consisted O
of O
4,446 O
subjects O
( O
Nfemales/Nmales O
= O
2,342/2,104 O
; O
mean O
age O
± O
s.d O
. O

= O
55.52 O
± O
7.62 O
years O
; O
age O
range O
= O
40–70 O
years O
) O
with O
quality-checked O
volumetric O
and O
DTI O
data O
for O
the O
analysis O
( O
conducted O
by O
UK O
Biobank O
, O
Brain O
Imaging O
Documentation O
V1.1 O
, O
http O
: O
//www.ukbiobank.ac.uk O
) O
. O

In O
the O
current O
study O
, O
subjects O
were O
excluded O
if O
they O
did O
not O
provide O
genetic O
data O
, O
or O
if O
they O
were O
known O
to O
have O
participated O
in O
studies O
from O
the O
Psychiatric O
Genomics O
Consortium O
( O
PGC O
) O
GWAS O
dataset O
as O
this O
was O
used O
to O
construct O
the O
polygenic O
risk O
scores O
( O
PGRS O
) O
. O

In O
total O
, O
the O
volumetric O
analysis O
included O
978 O
subjects O
( O
Nfemales/Nmales O
= O
499/479 O
; O
mean O
age O
± O
s.d O
. O

= O
55.32 O
± O
7.38 O
years O
; O
age O
range O
= O
40–70 O
years O
) O
and O
the O
DTI O
analysis O
included O
816 O
subjects O
( O
Nfemales/Nmales O
= O
413/403 O
; O
mean O
age O
± O
s.d O
. O

= O
55.49 O
± O
7.26 O
years O
; O
age O
range O
= O
40–70 O
years O
) O
. O

Sample O
overlap O
( O
individuals O
included O
in O
both O
the O
DTI O
and O
volumetric O
analysis O
) O
included O
N O
= O
816 O
participants O
and O
the O
volumetric O
analysis O
included O
N O
= O
162 O
extra O
participants O
. O

In O
addition O
, O
a O
sensitivity O
analysis O
was O
performed O
where O
we O
imposed O
internal O
imaging O
quality O
checks O
, O
excluding O
individuals O
whose O
subcortical O
volume O
or O
FA O
values O
were O
greater O
than O
three O
standard O
deviations O
above O
or O
below O
the O
mean O
for O
that O
measure O
. O

The O
sensitivity O
analysis O
, O
further O
referred O
to O
as O
the O
sample O
excluding O
outliers O
, O
included O
892 O
( O
exclusion O
of O
86 O
subjects O
; O
Nfemales/Nmales O
= O
477/415 O
; O
mean O
age O
± O
s.d O
. O

= O
55.29 O
± O
7.31 O
years O
; O
age O
range O
= O
40–70 O
years O
) O
and O
733 O
( O
exclusion O
of O
83 O
subjecs O
; O
Nfemales/Nmales O
= O
373/360 O
; O
mean O
age O
± O
s.d O
. O

= O
55.31 O
± O
7.22 O
years O
; O
age O
range O
= O
40–70 O
years O
) O
subjects O
for O
the O
volumetric O
and O
DTI O
analysis O
respectively O
. O

Sample O
overlap O
for O
the O
sample O
excluding O
outliers O
included O
N O
= O
679 O
, O
and O
the O
volumetric O
analysis O
included O
213 O
unique O
observations O
, O
whereas O
the O
DTI O
analysis O
included O
54 O
unique O
observations O
. O

This O
study O
has O
been O
approved O
by O
the O
National O
Health O
Service O
( O
NHS O
) O
Research O
Ethics O
Service O
( O
approval O
letter O
dated O
17th O
June O
2011 O
, O
reference O
: O
11/NW/0382 O
) O
, O
and O
by O
the O
UK O
Biobank O
Access O
Committee O
( O
Project O
# O
4844 O
) O
. O

All O
experiments O
were O
performed O
in O
accordance O
with O
guidelines O
and O
regulations O
from O
these O
committees O
. O

Written O
informed O
consent O
was O
obtained O
from O
each O
subject O
. O

Genotyping O
and O
derivation O
of O
polygenic O
risk O
scores O
Procedures O
for O
DNA O
collection O
and O
genotyping O
in O
UK O
Biobank O
have O
been O
described O
previously O
by O
Hagenaars O
et O
al O
.. O

Subjects O
were O
excluded O
from O
the O
PGRS O
analysis O
if O
they O
had O
a O
non-British O
ancestry O
, O
gender O
mismatch O
, O
relatedness O
( O
r O
> O
0.044 O
) O
, O
and O
genotype O
missingness O
bigger O
than O
2 O
% O
. O

PGRS O
for O
the O
three O
traits O
of O
interest O
( O
i.e. O
, O
MDD O
, O
SCZ O
, O
BP O
) O
were O
created O
using O
PRSice O
. O

For O
each O
subject O
PGRS O
were O
calculated O
by O
summing O
the O
number O
of O
risk O
alleles O
weighted O
by O
the O
strength O
of O
its O
association O
with O
the O
trait O
of O
interest O
. O

The O
strength O
of O
this O
association O
has O
been O
calculated O
previously O
by O
the O
PGC O
( O
PGC2 O
for O
SCZ O
) O
. O

Prior O
to O
calculating O
the O
PGRS O
, O
single O
nucleotide O
polymorphisms O
( O
SNPs O
) O
were O
excluded O
if O
they O
had O
a O
minor O
allele O
frequency O
less O
than O
1 O
% O
, O
deviated O
significantly O
from O
Hardy-Weinberg O
equilibrium O
( O
p O
< O
1 O
× O
10−6 O
) O
in O
the O
total O
sample O
of O
founder O
individuals O
, O
or O
had O
a O
call O
rate O
of O
less O
than O
99 O
% O
. O

The O
remaining O
SNPs O
were O
used O
to O
calculate O
15 O
multidimensional O
scaling O
( O
MDS O
) O
ancestry O
components O
( O
to O
account O
for O
population O
structure O
) O
. O

For O
the O
main O
results O
, O
the O
SNP O
inclusion O
threshold O
was O
set O
as O
p O
≤ O
0.5 O
, O
as O
Purcell O
et O
al O
. O

and O
studies O
following O
this O
work O
, O
have O
shown O
that O
this O
threshold O
is O
generally O
the O
most O
predictive O
of O
case-control O
status O
in O
subsequent O
studies O
. O

Using O
the O
p O
≤ O
0.5 O
SNP O
inclusion O
threshold O
, O
631,763 O
, O
5,422,836 O
and O
1,283,324 O
SNPs O
( O
after O
LD O
pruning O
) O
were O
included O
for O
the O
calculation O
of O
MDD-PGRS O
, O
SCZ-PGRS O
and O
BP-PGRS O
, O
respectively O
. O

Results O
generated O
by O
a O
SNP O
inclusion O
threshold O
of O
p O
≤ O
0.01 O
, O
p O
≤ O
0.05 O
, O
p O
≤ O
0.1 O
and O
p O
≤ O
1.0 O
are O
reported O
in O
supplementary O
materials O
. O

Image O
acquisition O
and O
Neuroimaging O
data O
pre-processing O
Procedures O
for O
image O
acquisition O
and O
pre-processing O
have O
been O
performed O
by O
UK O
Biobank O
, O
and O
are O
available O
on O
the O
UK O
Biobank O
website O
( O
http O
: O
//www.ukbiobank.ac.uk/ O
) O
, O
and O
have O
been O
documented O
previously O
. O

In O
short O
, O
images O
were O
collected O
in O
Cheadle O
Manchester O
on O
a O
Siemens O
Skyra O
3.0 O
T O
scanner O
( O
Siemens O
Medical O
Solutions O
, O
Germany O
) O
with O
a O
32-channel O
head O
coil O
( O
https O
: O
//www.healthcare.siemens.com/magnetic-resonance-imaging O
) O
. O

T1-weighted O
scans O
were O
acquired O
using O
a O
3D O
MPRAGE O
( O
resolution O
1 O
mm3 O
isotropic O
voxels O
) O
sequence O
, O
and O
diffusion-weighted O
( O
DW O
) O
scans O
were O
acquired O
with O
a O
monopolar O
Steejskal-Tanner O
pulse O
sequence O
and O
multi-shell O
acquisition O
( O
b0 O
= O
0 O
s/mm2 O
, O
b O
= O
1,000 O
s/mm2 O
, O
b O
= O
2,000 O
s/mm2 O
) O
. O

Images O
were O
preprocessed O
and O
analysed O
with O
the O
FMRIB O
Software O
Library O
( O
FSL O
) O
( O
http O
: O
//fsl.fmrib.ox.ac.uk/fsl O
) O
. O

More O
detailed O
information O
is O
reported O
in O
the O
supplementary O
materials O
. O

Statistical O
analysis O
All O
analyses O
were O
performed O
using O
R O
( O
version O
3.2.3 O
) O
in O
the O
Linux O
environment O
( O
R O
Development O
Core O
Team O
, O
2010 O
) O
. O

To O
examine O
whether O
higher O
PGRS O
were O
associated O
with O
globally O
poor O
WM O
microstructure O
, O
general O
components O
for O
FA O
( O
gFA O
) O
and O
MD O
( O
gMD O
) O
across O
the O
27 O
WM O
tracts O
were O
calculated O
. O

Latent O
measures O
, O
explaining O
a O
portion O
of O
variance O
WM O
structure O
, O
were O
calculated O
for O
both O
FA O
and O
MD O
by O
extracting O
the O
scores O
on O
the O
first O
unrotated O
components O
, O
using O
a O
principal O
component O
analysis O
( O
PCA O
) O
on O
the O
27 O
WM O
tracts O
. O

The O
first O
components O
accounted O
for O
a O
mean O
of O
44.82 O
% O
and O
41.73 O
% O
of O
total O
variance O
in O
FA O
and O
, O
47.45 O
% O
and O
45.35 O
% O
in O
MD O
, O
in O
the O
sample O
including O
and O
excluding O
outliers O
respectively O
( O
loadings O
of O
tracts O
on O
the O
first O
latent O
component O
> O
0.15 O
) O
. O

To O
examine O
whether O
higher O
PGRS O
were O
selectively O
associated O
with O
poor O
WM O
structure O
in O
a O
certain O
classification O
, O
this O
PCA O
was O
also O
performed O
separately O
for O
groups O
of O
different O
categories O
of O
WM O
tracts O
, O
including O
association O
( O
inferior O
fronto-occipital O
fasciculus O
, O
inferior O
longitudinal O
fasciculus O
, O
superior O
longitudinal O
fasciculus O
, O
uncinate O
fasciculus O
, O
cingulum O
) O
, O
projection O
( O
forceps O
minor O
, O
forceps O
major O
, O
corticospinal O
tracts O
, O
acoustic O
radiation O
, O
medial O
lemniscus O
, O
middle O
cerebellar O
peduncle O
) O
and O
thalamic O
radiation O
fibers O
, O
separately O
( O
sample O
including O
outliers O
: O
variance O
explained O
= O
54.52 O
% O
, O
38.68 O
% O
and O
61.92 O
% O
respectively O
for O
each O
subset O
, O
and O
loading O
of O
first O
component O
> O
0.33 O
; O
sample O
excluding O
outliers O
: O
variance O
explained O
= O
60.05 O
% O
, O
32.05 O
% O
and O
72.05 O
% O
respectively O
for O
each O
subset O
and O
loading O
of O
first O
component O
> O
0.27 O
) O
. O

For O
bilateral O
brain O
regions O
, O
associations O
between O
the O
three O
PGRS O
and O
each O
imaging O
measure O
were O
examined O
using O
a O
repeated O
measure O
linear O
mixed-effects O
analysis O
, O
modelling O
hemisphere O
as O
a O
random O
factor O
( O
where O
the O
PGRS O
* O
hemisphere O
interaction O
itself O
was O
found O
to O
be O
non-significant O
) O
. O

For O
unilateral O
structures O
( O
e.g O
. O

total O
GM O
volume O
, O
forceps O
major O
, O
forceps O
minor O
and O
middle O
cerebellar O
peduncle O
) O
, O
and O
those O
where O
there O
was O
a O
significant O
interaction O
between O
PGRS O
and O
hemisphere O
, O
associations O
were O
analysed O
as O
single O
structures O
without O
repeated O
measurements O
and O
without O
hemisphere O
as O
a O
separate O
term O
in O
the O
model O
. O

For O
all O
models O
, O
additional O
fixed O
effects O
included O
age O
, O
age2 O
, O
gender O
, O
genotype O
batch O
, O
genotype O
array O
and O
15 O
ancestry-informative O
MDS O
components O
. O

Intracranial O
volume O
, O
calculated O
as O
the O
sum O
of O
WM O
, O
GM O
and O
ventricular O
CSF O
, O
was O
also O
modelled O
as O
a O
fixed O
effect O
in O
the O
analysis O
of O
subcortical O
volumes O
in O
order O
to O
adjust O
for O
differences O
in O
overall O
brain O
size O
. O

PGRS O
and O
imaging O
measures O
were O
scaled O
to O
zero O
mean O
and O
unitary O
standard O
deviation O
. O

Standardised O
Beta O
values O
are O
reported O
throughout O
results O
. O

Results O
were O
corrected O
for O
multiple O
comparisons O
using O
a O
false O
discovery O
rate O
( O
FDR O
) O
correction O
. O

Nagelkerke O
’ O
s O
R2 O
was O
used O
to O
estimate O
the O
proportion O
of O
variation O
explained O
by O
PGRS O
. O

Post-hoc O
positive O
control O
analyses O
, O
with O
age O
as O
an O
independent O
variable O
and O
each O
of O
the O
brain O
measures O
as O
dependent O
variable O
, O
were O
performed O
in O
order O
to O
test O
the O
sensitivity O
of O
UK O
Biobank O
imaging O
data O
, O
by O
verifying O
that O
we O
could O
replicate O
the O
widely O
reported O
negative O
associations O
between O
many O
structural O
brain O
measures O
and O
age O
( O
including O
those O
reported O
previously O
in O
an O
overlapping O
sample O
in O
UK O
Biobank O
) O
. O

Fixed O
effects O
included O
gender O
for O
all O
structures O
, O
and O
side O
of O
hemisphere O
for O
lateralized O
structures O
only O
. O

